| abstract |
Use of a composition comprising cell membrane, or hydrophobic peptides derived from said cell membrane, for the reduction of lipolytic activity, retardation of fat digestion, suppression of appetite, decrease of body weight and/or lowering of blood lipids. Satiety for fat is mainly driven from the intestine. By the contact of fat with the intestinal mucosa, various satiety peptides are released, thus suppressing appetite and food intake. A reduced rate of fat digestion could optimise the satiety for fat, through prolonged release of satiety peptides. Fat digestion can be retarded by reduction of the lipolytic activity of pancreatic lipase. The examples show that fractions of plant cell membranes (thylakoids) inhibit the lipolytic activity of pancreatic lipase. |